Type of Deal |
Value |
Acquirer |
Target |
Adviser to acquirer (tax) |
Adviser to target (tax) |
Acquisition |
$2.18 billion |
Darling International |
Vion Ingredients |
K&L Gates / Clifford Chance |
|
Acquisition |
$1.6 billion |
Pacific Rubiales Energy |
Petrominerales |
Norton Rose Fulbright |
McCarthy Tetrault / Torys |
Acquisition |
$1.13 billion |
Aspen |
GSK (thrombosis drug brands) |
Bredin Prat - Julien Gayral / Slaughter & May |
|
Merger |
$1.1 billion |
Industrial Developments International |
Verde Realty Operating Partnership |
Weil, Gotshal & Manges - Scott Sontag |
|
Acquisition |
$1.05 billion |
Vista Equity Partners |
Active Network |
Kirkland & Ellis |
DLA Piper |
Acquisition |
$930 million |
Monsanto Company |
Climate Corporation |
Latham & Watkins |
Wilson Sonsini Goodrich & Rosati |
Acquisition |
$453 million |
Ultrapar Participações |
Imifarma Produtos Farmacêuticos e Cosméticos |
Lefosse Advogados |
|
Acquisition |
$280 million |
Hochschild Mining |
International Minerals |
Stikeman Elliott - Dean Kraus, John O’Connor |
|
Acquisition |
Undisclosed |
AXA Liabilities Managers |
Global Reinsurance |
Stikeman Elliott |
|
Acquisition |
Undisclosed |
GPVTL Canada |
Xtreme Labs |
Stikeman Elliott |
|
Type of Deal |
Value |
Issuer/Borrower |
Lead managers/arrangers |
Adviser to issuer/borrower (tax) |
Adviser to lead managers (tax) |
Senior Notes Offering |
$4.5 billion |
General Motors Company |
Citigroup |
Jenner & Block |
Davis Polk & Wardwell - Samuel Dimon |
Convertible Bonds Issue |
$641.4 million |
CapitaLand |
Credit Suisse |
Allen & Overy / Allen & Gledhill |
Linklaters / WongPartnership |
Senior Notes Offering |
$500 million |
Marsh & McLennan Companies |
Goldman Sachs / HSBC / Merrill Lynch / Deutsche Bank |
Davis Polk & Wardwell - Lucy Farr |
Willkie Farr & Gallagher |
Initial Public Offering |
$192.3 million |
Ophthotech Corporation |
Morgan Stanley / JP Morgan |
Wilmer Cutler Pickering Hale and Dorr |
Davis Polk & Wardwell |
Deals of the week - October 7 2013
